1	Current	Current	B-NP	JJ	O	2	NMOD	0
2	prospects	prospect	I-NP	NNS	O	20	NMOD	0
3	for	for	B-PP	IN	O	2	NMOD	0
4	controlling	control	B-VP	VBG	O	3	PMOD	16	controlling
5	cancer	cancer	B-NP	NN	O	6	NMOD	0
6	growth	growth	I-NP	NN	O	4	OBJ	4	growth
7	with	with	B-PP	IN	O	6	NMOD	0
8	non-cytotoxic	non-cytotoxic	B-NP	JJ	O	9	NMOD	0
9	agents	agent	I-NP	NNS	O	7	PMOD	0
10	--	--	O	:	O	2	P	0
11	nutrients	nutrient	B-NP	NNS	O	20	NMOD	0
12	,	,	O	,	O	20	P	0
13	phytochemicals	phytochemical	B-NP	NNS	O	20	NMOD	0
14	,	,	O	,	O	20	P	0
15	herbal	herbal	B-NP	JJ	O	16	NMOD	0
16	extracts	extract	I-NP	NNS	O	20	NMOD	0
17	,	,	O	,	O	20	P	0
18	and	and	O	CC	O	20	NMOD	0
19	available	available	B-NP	JJ	O	20	NMOD	0
20	drugs	drug	I-NP	NNS	O	0	ROOT	0
21	.	.	O	.	O	20	P	0

1	In	In	B-PP	IN	O	14	VMOD	0
2	animal	animal	B-NP	NN	O	6	NMOD	0
3	or	or	O	CC	O	6	NMOD	0
4	cell	cell	B-NP	NN	O	6	NMOD	0
5	culture	culture	I-NP	NN	O	6	NMOD	19	culture
6	studies	study	I-NP	NNS	O	1	PMOD	0
7	,	,	O	,	O	14	P	0
8	the	the	B-NP	DT	O	11	NMOD	0
9	growth	growth	I-NP	NN	O	11	NMOD	4	growth
10	and	and	I-NP	CC	O	11	NMOD	0
11	spread	spread	I-NP	NN	O	14	SUB	14	spread
12	of	of	B-PP	IN	O	11	NMOD	0
13	cancer	cancer	B-NP	NN	O	12	PMOD	0
14	can	can	B-VP	MD	O	0	ROOT	0
15	be	be	I-VP	VB	O	14	VC	0
16	slowed	slow	I-VP	VBN	O	15	VC	18	slowed
17	by	by	B-PP	IN	O	16	VMOD	0
18	many	many	B-NP	JJ	O	19	NMOD	0
19	nutrients	nutrient	I-NP	NNS	O	17	PMOD	0
20	,	,	O	,	O	31	P	0
21	food	food	B-NP	NN	B-protein	22	NMOD	0
22	factors	factor	I-NP	NNS	I-protein	31	NMOD	0
23	,	,	O	,	O	31	P	0
24	herbal	herbal	B-NP	JJ	O	25	NMOD	0
25	extracts	extract	I-NP	NNS	O	31	NMOD	0
26	,	,	O	,	O	31	P	0
27	and	and	O	CC	O	31	NMOD	0
28	well-tolerated	well-tolerated	B-NP	JJ	O	30	AMOD	0
29	,	,	I-NP	,	O	30	P	0
30	available	available	I-NP	JJ	O	31	NMOD	0
31	drugs	drug	I-NP	NNS	O	14	VMOD	0
32	that	that	B-NP	WDT	O	31	NMOD	0
33	are	be	B-VP	VBP	O	32	SBAR	0
34	still	still	I-VP	RB	O	33	VMOD	0
35	rarely	rarely	I-VP	RB	O	33	VMOD	0
36	used	use	I-VP	VBN	O	33	VC	0
37	in	in	B-PP	IN	O	36	VMOD	0
38	the	the	B-NP	DT	O	40	NMOD	0
39	clinical	clinical	I-NP	JJ	O	40	NMOD	0
40	management	management	I-NP	NN	O	37	PMOD	0
41	of	of	B-PP	IN	O	40	NMOD	0
42	cancer	cancer	B-NP	NN	O	41	PMOD	0
43	,	,	O	,	O	31	P	0
44	in	in	B-PP	IN	O	14	VMOD	0
45	part	part	B-NP	NN	O	44	PMOD	0
46	because	because	B-SBAR	IN	O	14	VMOD	0
47	they	they	B-NP	PRP	O	48	SUB	0
48	seem	seem	B-VP	VBP	O	46	SBAR	0
49	unlikely	unlikely	B-ADJP	JJ	O	48	PRD	0
50	to	to	B-VP	TO	O	51	VMOD	0
51	constitute	constitute	I-VP	VB	O	49	AMOD	0
52	definitive	definitive	B-NP	JJ	O	53	NMOD	0
53	therapies	therapy	I-NP	NNS	O	51	OBJ	0
54	in	in	B-PP	IN	O	51	VMOD	0
55	themselves	themselves	B-NP	PRP	O	54	PMOD	0
56	.	.	O	.	O	14	P	0

1	However	However	B-ADVP	RB	O	4	VMOD	0
2	,	,	O	,	O	4	P	0
3	it	it	B-NP	PRP	O	4	SUB	0
4	is	be	B-VP	VBZ	O	30	VMOD	0
5	reasonable	reasonable	B-ADJP	JJ	O	4	PRD	0
6	to	to	B-VP	TO	O	7	VMOD	0
7	expect	expect	I-VP	VB	O	5	AMOD	0
8	that	that	B-SBAR	IN	O	7	VMOD	0
9	mechanistically	mechanistically	B-NP	RB	O	10	AMOD	0
10	complementary	complementary	I-NP	JJ	O	11	NMOD	0
11	combinations	combination	I-NP	NNS	O	15	SUB	0
12	of	of	B-PP	IN	O	11	NMOD	0
13	these	these	B-NP	DT	O	14	NMOD	0
14	measures	measure	I-NP	NNS	O	12	PMOD	0
15	could	could	B-VP	MD	O	8	SBAR	0
16	have	have	I-VP	VB	O	15	VC	0
17	a	a	B-NP	DT	O	19	NMOD	0
18	worthwhile	worthwhile	I-NP	JJ	O	19	NMOD	0
19	impact	impact	I-NP	NN	O	16	OBJ	0
20	on	on	B-PP	IN	O	16	VMOD	0
21	survival	survival	B-NP	NN	O	22	NMOD	0
22	times	time	I-NP	NNS	O	20	PMOD	0
23	and	and	O	CC	O	30	VMOD	0
24	,	,	O	,	O	30	P	0
25	when	when	B-ADVP	WRB	O	30	VMOD	0
26	used	use	B-VP	VBN	O	25	SBAR	0
27	as	as	B-PP	IN	O	26	VMOD	0
28	adjuvants	adjuvant	B-NP	NNS	O	27	PMOD	0
29	,	,	O	,	O	30	P	0
30	could	could	B-VP	MD	O	0	ROOT	0
31	improve	improve	I-VP	VB	O	30	VC	0
32	the	the	B-NP	DT	O	34	NMOD	0
33	cure	cure	I-NP	NN	O	34	NMOD	0
34	rates	rate	I-NP	NNS	O	31	OBJ	0
35	achievable	achievable	B-ADJP	JJ	O	34	NMOD	0
36	with	with	B-PP	IN	O	35	AMOD	0
37	standard	standard	B-NP	JJ	O	38	NMOD	0
38	therapies	therapy	I-NP	NNS	O	36	PMOD	0
39	.	.	O	.	O	30	P	0

1	The	The	B-NP	DT	O	3	NMOD	0
2	therapeutic	therapeutic	I-NP	JJ	O	3	NMOD	0
3	options	option	I-NP	NNS	O	8	SUB	0
4	available	available	B-ADJP	JJ	O	3	NMOD	0
5	in	in	B-PP	IN	O	4	AMOD	0
6	this	this	B-NP	DT	O	7	NMOD	0
7	regard	regard	I-NP	NN	O	5	PMOD	0
8	include	include	B-VP	VBP	O	17	VMOD	0
9	measures	measure	B-NP	NNS	O	8	OBJ	0
10	that	that	B-NP	WDT	O	9	NMOD	0
11	:	:	O	:	O	10	P	0
12	down-regulate	down-regulate	B-VP	VBP	O	10	SBAR	18	down-regulate
13	serum	serum	B-NP	NN	O	15	NMOD	0
14	free	free	I-NP	JJ	O	15	NMOD	0
15	IGF-I	IGF-I	I-NP	NN	O	12	OBJ	0
16	;	;	O	:	O	17	P	0
17	suppress	suppress	B-VP	VBP	O	0	ROOT	18	suppress
18	the	the	B-NP	DT	O	19	NMOD	0
19	synthesis	synthesis	I-NP	NN	O	17	OBJ	8	synthesis
20	of	of	B-PP	IN	O	19	NMOD	0
21	mevalonic	mevalonic	B-NP	JJ	O	22	NMOD	0
22	acid	acid	I-NP	NN	O	25	NMOD	0
23	and/or	and/or	O	CC	O	25	NMOD	0
24	certain	certain	B-NP	JJ	O	25	NMOD	0
25	derivatives	derivative	I-NP	NNS	O	20	PMOD	0
26	thereof	thereof	B-ADVP	RB	O	25	NMOD	0
27	;	;	O	:	O	17	P	0
28	modulate	modulate	B-VP	VB	O	17	VMOD	16	modulate
29	arachidonate	arachidonate	B-NP	NN	O	30	NMOD	0
30	metabolism	metabolism	I-NP	NN	O	28	OBJ	0
31	by	by	B-PP	IN	O	28	VMOD	0
32	inhibiting	inhibit	B-VP	VBG	O	31	PMOD	18	inhibiting
33	5-lipoxygenase	5-lipoxygenase	B-NP	NN	B-protein	38	NMOD	0
34	,	,	O	,	O	38	P	0
35	12-lipoxygenase	12-lipoxygenase	B-NP	NN	B-protein	38	NMOD	0
36	,	,	O	,	O	38	P	0
37	or	or	O	CC	O	38	NMOD	0
38	COX-2	COX-2	B-NP	NN	B-protein	32	OBJ	0
39	;	;	O	:	O	17	P	0
40	antagonize	antagonize	B-VP	VB	O	17	VMOD	18	antagonize
41	the	the	B-NP	DT	O	42	NMOD	0
42	activation	activation	I-NP	NN	O	40	OBJ	17	activation
43	of	of	B-PP	IN	O	42	NMOD	0
44	AP-1	AP-1	B-NP	NN	B-protein	46	NMOD	0
45	transcription	transcription	I-NP	NN	I-protein	46	NMOD	0
46	factors	factor	I-NP	NNS	I-protein	43	PMOD	0
47	;	;	O	:	O	48	P	0
48	promote	promote	B-VP	VB	O	17	VMOD	17	promote
49	the	the	B-NP	DT	O	50	NMOD	0
50	activation	activation	I-NP	NN	O	48	OBJ	17	activation
51	of	of	B-PP	IN	O	50	NMOD	0
52	PPAR-gamma	PPAR-gamma	B-NP	NN	B-protein	54	NMOD	0
53	transcription	transcription	I-NP	NN	I-protein	54	NMOD	0
54	factors	factor	I-NP	NNS	I-protein	51	PMOD	0
55	;	;	O	:	O	57	P	0
56	and	and	O	CC	O	57	DEP	0
57	that	that	B-NP	WDT	O	48	VMOD	0
58	suppress	suppress	B-VP	VBP	O	57	SBAR	18	suppress
59	angiogenesis	angiogenesis	B-NP	NN	O	58	OBJ	3	angiogenesis
60	by	by	B-PP	IN	O	58	VMOD	0
61	additional	additional	B-NP	JJ	O	62	NMOD	0
62	mechanisms	mechanism	I-NP	NNS	O	60	PMOD	0
63	.	.	O	.	O	17	P	0

1	Many	Many	B-NP	JJ	O	5	SUB	0
2	of	of	B-PP	IN	O	1	NMOD	0
3	these	these	B-NP	DT	O	4	NMOD	0
4	measures	measure	I-NP	NNS	O	2	PMOD	0
5	appear	appear	B-VP	VBP	O	0	ROOT	0
6	suitable	suitable	B-ADJP	JJ	O	5	PRD	0
7	for	for	B-PP	IN	O	6	AMOD	0
8	use	use	B-NP	NN	O	7	PMOD	0
9	in	in	B-PP	IN	O	8	NMOD	0
10	cancer	cancer	B-NP	NN	O	11	NMOD	0
11	prevention	prevention	I-NP	NN	O	9	PMOD	18	prevention
12	.	.	O	.	O	5	P	0

